Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

1,239 trials

NCT07535905
Recruiting
Clinical Trial to Observe the Effects of Tamoxifen on Testosterone Recovery in Medically Castrated Prostate Cancer Patients
Phase 2 · Canada · 1 site
Registry update: 22 Oct 2026
NCT07790718
Recruiting
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
Not applicable · United States · 2 sites
Registry update: 28 Aug 2026
NCT07526545
Recruiting
Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial
Not applicable · United States · 1 site
Registry update: 15 Oct 2026
NCT07725523
Recruiting
Safety and Efficacy of OTL78
Phase 2/3 · United States · 2 sites
Registry update: 22 Oct 2026
NCT07466498
Recruiting
Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial
Phase 2 · United States · 1 site
Registry update: 2 Nov 2026
NCT07518888
Recruiting
Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer
Not applicable · United States · 1 site
Registry update: 23 Oct 2026
NCT07278362
Recruiting
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Phase 4 · United States · 2 sites
Registry update: 2 Nov 2026
NCT07698535
Recruiting
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
Phase 2 · United States · 1 site
Registry update: 19 Oct 2026
NCT07667400
Recruiting
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
Phase 1/2 · United States · 1 site
Registry update: 6 Nov 2026
NCT07574541
Recruiting
Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
Phase 2 · United States · 1 site
Registry update: 6 Nov 2026
NCT06960798
Recruiting
Characterizing the Genomic Landscape of Cancer in Native American Populations (NAT-Geno)
Not applicable · United States · 1 site
Registry update: 13 Oct 2026
2026-526406-32-00
Recruiting
A study to test a new drug (TRP-001) given before prostate cancer surgery in patients with very high-risk Prostate cancer.”
Phase 1 · Germany · 1 site
Registry update: 4 Sept 2026
NCT07887971
Recruiting
A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
Phase 1 · United States · 2 sites
Registry update: 2 Nov 2026
NCT07221825
Recruiting
Low-Count Quantitative SPECT for Men Treated With Radium-223
Not applicable · United States · 1 site
Registry update: 15 Oct 2026
NCT07685249
Recruiting
Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment
Not applicable · United States · 1 site
Registry update: 6 Nov 2026
NCT07906717
Recruiting
A Study of JNJ-101556143 With Best Supportive Care in Participants With Metastatic Prostate Cancer
Phase 3 · Israel, United States · 4 sites
Registry update: 3 Nov 2026
NCT07824349
Recruiting
JUR-003 in Adult Patients With Metastatic Prostate Cancer
Phase 1 · United States · 4 sites
Registry update: 4 Nov 2026
NCT07859722
Recruiting
CT- Versus MRI-Based Planning for High-Dose-Rate Prostate Brachytherapy for Prostate Cancer
Not applicable · United States · 3 sites
Registry update: 2 Nov 2026
NCT07885423
Recruiting
68Ga-XMFH01 PET/Fluorescence Imaging in Prostate Cancer
Not applicable · China · 1 site
Registry update: 6 Nov 2026
NCT07609225
Recruiting
Chemical-Shift-Encoded MRI for Active Bone Marrow Dosimetry in Radiopharmaceutical Therapy
Early phase 1 · United States · 1 site
Registry update: 23 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.